Natus Medical Inc. delivered its 10-K annual report to the U.S. Securities and Exchange Commission on February 25, 2022.Natus provides innovative healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.The Company’s neoBLUE Product Family product line consists of our neoBLUE Overhead, neoBLUE Compact and…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
